Wishing everyone a joyful 2025! Together, let’s keep advancing science for a healthier tomorrow. #smabiolabs #happynewyear #2025 #health #innovation #science
SmaBio Labs
Pharmaceutical Manufacturing
Durham, North Carolina 802 followers
Empowering discoveries. Transforming lives.
About us
Accelerate your molecule's journey from discovery to commercialization with SmaBio Labs, a dynamic CDMO specializing in Chemistry Manufacturing and Control (CMC). With a focus on efficiency and precision, SmaBio Labs offers cutting-edge solutions to fast-track our partner's drug discovery, formulation development, and analytical development programs. We are a team of top tier scientists with 100+ years of experience, dedicated to providing reliable and streamlined services with thoughtful planning and meticulous execution.
- Website
-
smabiolabs.com
External link for SmaBio Labs
- Industry
- Pharmaceutical Manufacturing
- Company size
- 11-50 employees
- Headquarters
- Durham, North Carolina
- Type
- Privately Held
- Specialties
- Research & Development, Small Molecules R&D, and Clinical Trial Material
Locations
-
Primary
1021 W Williams St
Suite #102
Durham, North Carolina 27502, US
Employees at SmaBio Labs
-
Bharathi Pandi
SmaBio Labs, Co-Founder & Chief Scientific Officer (Drug Discovery Services - Synthesis, Formulation, Analytical and CTM GMP Synthesis)
-
Sucharitha Murugu
RN Turned HealthTech Product Manager | Bridging Clinical Insight & Tech | Creating User-Centric Solutions in HealthTech & Non-Profit Sector | Driving…
-
Jyothi Bolledula
Pharmaceutical professional at SmaBio Labs
-
Aishwarya Madarla
Scientist- I at SmaBio Labs
Updates
-
Flow chemistry is transforming pharmaceutical manufacturing, enabling more efficient and scalable production of APIs. By enhancing reaction control, improving safety, and reducing waste, this method paves the way for faster and greener processes. The integration of AI and machine learning further optimizes reaction conditions, enhancing sustainability while driving innovation in chemical synthesis. As the pharmaceutical industry continues to embrace these advancements, continuous flow chemistry is set to redefine drug development. Explore how this technology is shaping the future of pharmaceutical manufacturing. Visit Smabiolabs.com for details. #flowchemistry #smabiolabs #pharmaceuticalindustry #innovation #APIproduction #sustainability
-
Wishing you and your loved ones a Merry Christmas filled with joy, peace, and cherished moments! #Christmasday #merrychristmas #happyholidays #smabiolabs #health
-
Unnatural amino acids (UAAs) are redefining the future of drug development. From improving drug stability and extending half-life to facilitating precise antibody-drug conjugates, UAAs are driving innovation in precision medicine and protein therapeutics. Discover how these transformative molecules are bridging the gap between biologics and small molecules to create next-generation therapies. 👉 Read the full article to explore the latest advancements and their potential to revolutionize healthcare. #Drugdiscovery #Biotechinnovation #Precisionmedicine #SmaBioLabs
-
Thrilled to have hosted NC DEFTECH’s Holiday Coffee Call at SmaBio Labs! It was a great discussion on innovation and collaboration for 2025. We look forward to hosting more such impactful events in the future! #Innovation #NationalSecurity #Collaboration #Biotech #Defense
🎄 Closing Out 2024 with a Powerful DEFTECH Christmas Special Coffee Call🎄 A heartfelt thank you to Bharathi Pandi, Chief Scientific Officer of SmaBio Labs, for graciously hosting today’s session and sharing insights into the cutting-edge innovations driving defense and biotech forward. We delved into the National Defense Authorization Act 2025, the threats facing our nation, briefing from the Defense Innovation Unit (DIU), and strategies to position our defense industrial base and innovation ecosystem for success in the coming year. Thank you to Ana Muresan from the USPTO for sharing IP protection strategies for 2025. Let’s keep the momentum going! Join us for our next DEFTECH Coffee Call on Friday January 3, 2025, as we kick off the new year with purpose, innovation, and collaboration. Wishing you a Merry Christmas and a holiday season filled with peace and joy. Here’s to a safe, successful, and innovative 2025! #DEFTECH #NationalSecurity #Innovation #DefenseIndustrialBase #MerryChristmas North Carolina Military Business Center
-
As we gather around this table, we’re reminded that every milestone achieved at SmaBio Labs is the result of a shared vision, relentless dedication and the unwavering support of our team, partners and community. This dinner is more than a celebration of one remarkable year—it’s a reflection of the passion and purpose that drive us to innovate and contribute to solving major healthcare challenges. #smabiolabs #team #community #innovation #celebration #healthcare
-
The proposed Biosecure Act could transform the pharmaceutical industry, prioritizing resilient, localized supply chains and addressing today’s global challenges. In many ways, it’s a call to rethink how we innovate, manufacture, and deliver impactful therapies. At SmaBio Labs, we see this as an opportunity to empower our partners with agile solutions, streamlined operations, and cutting-edge capabilities—all while keeping innovation at the forefront. Reshoring manufacturing isn’t just a shift in process; it’s a chance to build a more adaptable, efficient, and future-ready industry. As we prepare to navigate these changes together, we’re excited about the possibilities for collaboration, transformation, and progress. What opportunities or challenges do you see with the Biosecure Act? Let’s connect and explore how we can shape the future of healthcare, together. #ShapingPharma #BiosecureAct #ResilientSupplyChains #FutureReadyHealthcare
With the U.S. Congress reviewing the Biosecure Act, concerns over clinical and commercial supply chains are intensifying, particularly as reshoring manufacturing gains momentum. Syner-G BioPharma Group supports these changes with: - Supplier Selection: Vetting labs and CDMOs - Tech Transfers: Seamless transfer plans - Skilled Expertise: Method development and formulation - Local Presence: “Person-in-plant” support in the U.S. and India Let’s connect to discuss streamlining your operations in response to these shifts: https://lnkd.in/eRAW_ewD #BiosecureAct #ClinicalSupplyChains #TechTransfer
-
Meet Sucharitha Murugu – the creative force behind our marketing and communications at SmaBio Labs! At SmaBio Labs, we know that our success begins with our people, and Sucharitha Murugu, our Marketing & Communications Manager, exemplifies this. With a Bachelor’s in Nursing from Campbell University and over six years of healthcare experience, Suchritha brings a unique perspective to her role. Her specialized certification in Product Management allows her to seamlessly connect scientific innovation with real-world impact, creating strategies that elevate SmaBio Labs in the pharmaceutical industry. What truly sets Sucharitha apart is her ability to transform complex pharmaceutical advancements into stories that resonate. Her creative vision, combined with her deep understanding of patient care and healthcare innovation, ensures that SmaBio Labs consistently stands out in an ever-evolving landscape. Her leadership is rooted in collaboration, innovation, and a client-first mindset, making her a cornerstone of our team. Beyond her professional contributions, Sucharitha’s passion for creative ventures and staying ahead of industry trends inspires everyone around her. We are proud to have Sucharitha as part of the SmaBio Labs family. Join us in celebrating her incredible contributions as we continue to innovate and grow together! #SmaBioLabs #Marketing #CDMO #Healthcare #Innovation #PharmaceuticalIndustry #communication
-
Developing advanced sustained-release dosage forms ensures consistent therapeutic effects, enhanced patient compliance, and optimized drug delivery. These systems are especially impactful in managing chronic conditions like cardiovascular diseases, where controlled, precise drug release can improve outcomes and quality of life. SmaBio Labs leverages cutting-edge formulation techniques and innovative release mechanisms to design solutions tailored to your molecule's unique properties. From concept to commercialization, we ensure efficiency and precision at every stage of development. Curious about the science behind sustained-release formulations and their role in cardiovascular therapies? Visit smabiolabs.com to explore the details. #SustainedRelease #DrugDelivery #CDMO #Innovation #SmaBioLabs #cardiovascularmedication
-
"Our goal has always been to go above and beyond in advancing scientific progress." As Bharathi Pandi, PhD, CSO & Co-Founder of SmaBio Labs, emphasizes, this expansion is more than just growth. It's a pivotal step that enhances our ability to support clients at every stage of drug development, from discovery to commercialization. With these expanded capabilities, we’re now better equipped than ever to help our partners navigate the complexities of drug development and bring transformative solutions to market. Curious about how we can empower your journey? Connect with Bharathi Pandi or visit our website smabiolabs.com to learn more about our cutting-edge services. #drugdevelopment #discovery #CDMO #Pharmaceuticaldevelopment